Prenatal acetaminophen study raises questions, not proof of harm
A Danish study of about 300 infant girls associated prenatal paracetamol, or acetaminophen, exposure with smaller ovaries at three months; researchers also reported smaller testes on average among exposed infant boys.[3] The research did not establish that the medicine caused the differences or tha…
A Danish study of about 300 infant girls associated prenatal paracetamol, or acetaminophen, exposure with smaller ovaries at three months; researchers also reported smaller testes on average among exposed infant boys.[3] The research did not establish that the medicine caused the differences or that the observed changes will affect adult fertility, and doctors said acetaminophen remains appropriate during pregnancy when needed.[3][7]
Why it matters: The findings warrant longer-term reproductive research, but the absence of demonstrated causation or known fertility consequences means they do not currently justify stopping medically needed acetaminophen during pregnancy.[3][7]
Key insights: Exposed girls had ovaries that were 40% smaller by volume, uteruses that were 13% smaller and 23% fewer ovarian follicles on average than unexposed girls.[3] | Higher doses were associated with larger differences, although none of the women exceeded the recommended daily maximum of 4,000 milligrams.[3] | A separate dataset involving 1,210 Copenhagen-born girls also linked fetal exposure with smaller ovaries during adolescence.[3] | Animal studies found reduced fertility and earlier reproductive ageing after similar effects, but researchers said it remains unclear whether those outcomes apply to humans.[3]
Cheatsheet facts: What changed: Researchers reported an association between prenatal acetaminophen exposure and smaller reproductive organs in infant girls and boys.[3] | Why now: The paper covering girls was published on 9 September 2026, while the separate boys’ paper had been accepted but was not yet published.[3] | Watch next: Long-term follow-up measuring fertility and reproductive ageing would show whether the anatomical differences have clinical consequences.[3]
A Danish study of about 300 infant girls associated prenatal paracetamol, or acetaminophen, exposure with smaller ovaries at three months; researchers also reported smaller testes on average among exposed infant boys.[3] The research did not establish that the medicine caused the differences or that the observed changes will affect adult fertility, and doctors said acetaminophen remains appropriate during pregnancy when needed.[3][7]
Why it matters: The findings warrant longer-term reproductive research, but the absence of demonstrated causation or known fertility consequences means they do not currently justify stopping medically needed acetaminophen during pregnancy.[3][7]
Key insights: Exposed girls had ovaries that were 40% smaller by volume, uteruses that were 13% smaller and 23% fewer ovarian follicles on average than unexposed girls.[3] | Higher doses were associated with larger differences, although none of the women exceeded the recommended daily maximum of 4,000 milligrams.[3] | A separate dataset involving 1,210 Copenhagen-born girls also linked fetal exposure with smaller ovaries during adolescence.[3] | Animal studies found reduced fertility and earlier reproductive ageing after similar effects, but researchers said it remains unclear whether those outcomes apply to humans.[3]
Cheatsheet facts: What changed: Researchers reported an association between prenatal acetaminophen exposure and smaller reproductive organs in infant girls and boys.[3] | Why now: The paper covering girls was published on 9 September 2026, while the separate boys’ paper had been accepted but was not yet published.[3] | Watch next: Long-term follow-up measuring fertility and reproductive ageing would show whether the anatomical differences have clinical consequences.[3]